Immunomodulatory activity of a lupane triterpenoid ester isolated from the eastern Nigeria mistletoe, Loranthus micranthus (Linn)  by Ogechukwu, Omeje Edwin et al.
514 Asian Pacific Journal of Tropical Medicine (2011)514-522
Document heading          doi:  
Immunomodulatory activity of a lupane triterpenoid ester isolated from 
the eastern Nigeria mistletoe, Loranthus micranthus (Linn)
Omeje Edwin Ogechukwu1*, Osadebe Patience Ogoamaka1, Nworu Chukwuemeka Sylvester2, 
Akira Kawamura3, Peter Proksch4
1Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, University of Nigeria, 410001, Nsukka, Nigeria
2Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, 410001, Nsukka, Nigeria
3Department of Chemistry, Hunter College of CUNY, The City University of New York, U.S.A
4Department of Pharmaceutical Biology, Heinrich-Hein University, Düsseldorf, Germany
 Contents lists available at ScienceDirect
Asian Pacific Journal of Tropical Medicine
journal homepage:www.elsevier.com/locate/apjtm
ARTICLE INFO                           ABSTRACT
Article history:
Received 21 February 2011
Received in revised form 11 April 2011
Accepted 15 April 2011
Available online 20 July 2011
Keywords:
Lupane triterpenoid
Loranthus micranthus
Eastern Nigeria mistletoe
Interleukin-8
Cell proliferation
Anti-inflammatory
  *Corresponding author: Omeje Edwin Ogechukwu, Department of Pharmaceutical and 
Medicinal Chemistry.
    Tel: +234-803-549-5441
    E-mail: winnomeje@yahoo.com; edwin.omeje@unn.edu.ng
1. Introduction
  The complex human immune system could be described 
aptly as an orchestra for the maintenance of homeostasis 
by its intricate ability to modulate myriads of immune 
responses. This action of the immune system precipitates 
strong defense against pathogens that frequently assaults the 
human health integrity[1]. Modulation of the immune system 
involves either stimulation on one part, or suppression at 
the other extreme[2]. The stimulation of defense mechanistic 
pathways has been recognized as a possible means of 
inhibiting disease progression in humans without, per 
se, eliciting harmful effects[3,4]. It is now recognized that 
immunomodulatory therapy could provide an alternative 
to conventional chemotherapy of a variety of disease 
conditions[5]. Essentially, immunomodulatory agents of 
plant origin are claimed to induce paraimmunity, the non-
specific immunomodulation of granulocytes, macrophages, 
natural killer cells and complement functions[6,7]. They 
do so by maintaining body homeostasis[8] and through 
adaptogenic activities[9,10]. Furthermore, the emergence 
of acquired immunodeficiency syndrome (AIDS), in the 
1980s and the concern about bioterrorism have increased 
the emphasis on the role of immune system in defending 
individuals against diseases[11]. Mistletoes are semi-
parasitic ever-green plants which depend on their host 
tree for minerals and water only but photosynthesize their 
carbohydrate by means of its green leaves[12]. They grow on 
a variety of evergreen and deciduous trees. Over 700 species 
Objective: To provide further evidence for the ethnomedicinal use of the Eastern Nigeria 
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of the mistletoe plants are known world-wide[13]. Scientific 
studies, especially of the European mistletoe have shown 
that composition or activities of mistletoe are dependent 
on the host tree, species and harvesting period[14-18].
The macromolecular and micromolecular components 
of different species of mistletoes sourced from various 
host trees may also vary. The Eastern Nigeria mistletoe, 
Loranthus micranthus (L. micranthus) has been employed 
traditionally in management of various ailments, notably 
diabetes, high blood pressure and conditions affecting 
human immune system for many years. Aqueous decoctions 
or alcoholic extracts of L. micranthus have diverse folkloric 
claims of effectiveness for treatment of epilepsy, diabetes, 
hypertension, cardiovascular diseases, menopausal 
syndrome, infertility, rheumatism, agglutination and in 
conditions generally requiring modulation of the immune 
system. It is equally used locally as an antimicrobial and 
antispasmodic agent.  The morphology, distribution and 
some biological activities of mistletoes in Nigeria, and in 
particular, Eastern Nigeria has been well-documented[19]. 
The present study involves the bio-assay guided isolation 
and characterization of the immunomodulatory constituents 
of the Eastern Nigeria mistletoe from the n-hexane fraction 
of the crude extract obtained from the host tree, Kola 
acuminate (K. acuminata) using cell proliferation studies 
by flow cytometry technique and real time polymerase chain 
reaction assay. To the best of our knowledge, this is the first 
attempt to isolate and characterize chemical constituents 
from Eastern Nigeria mistletoe, L. micranthus.
2. Materials and methods
2.1. Plant material
  L. micranthus Linn. (Loranthaceae) leaves parasitic on 
the host tree K. acuminate were collected in April, 2007 
from different locations in Nsukka LGA, Enugu State. 
The leaves were identified and certified by Mr. A. O. 
Ozioko, a taxonomist of the Bioresources Development and 
Conservation Programme (BDCP), Nsukka, Enugu State. 
Voucher specimens were kept at the BDCP Centre with the 
number BDC-532-07 for reference purposes.
2.2. Solvents and reagents
  The following chemicals were procured and used in the 
research: Analar grade methanol, n-hexane, ethylacetate, 
acetone, chloroform (Sigma Aldrich; Germany). Distilled 
water (Department of Pharmaceutical & Medicinal 
Chemistry, University of Nigeria), normal saline (DANA Ltd), 
dimethylsulphoxide (DMSO), Tween 20 or 80 solution (BDH, 
England), silica gel (70-230 and 60-120 mesh sizes), silica 
gel G60, precoated silica gel GF254, (Merck, Germany) were 
also used. All other reagents were of analytical grade or 
freshly prepared. Absence of water in analar grade solvents 
was confirmed by charge transfer complexation process 
using chloranilic acid as the π-electron acceptor. When 
necessary, such solvents were redistilled.
2.3. Equipment
  The following items of equipment were used: Gallenkamp 
or Electrothermal melting point apparatus (England; used 
uncorrected), HREIMS and EIMS (mass spectrometers) 
linked to a MATT 8200 recorder, at the Institute of Anorganic 
Chemistry and Structure Chemistry, Heinrich-Heine-
Universität, Düsseldorf, Germany and FT-IR spectrometer 
(Shimadzu, Japan) at the Department of Chemistry, Usmanu 
Dan Fodiyo University, Sokoto, GC-MS analyses were done 
with (GCMS-QP2010 Plus, Shimadzu, Japan) with a  mass 
selective detector coupled to GC-2010 gas chromatograph 
at the National Research Institute of Chemical Technology 
(NARICT), Zaria, Kaduna State, Nigeria.
  1HNMR, 13CNMR, were recorded with BRUKER-500 MHz 
spectrophotometer in CD3OD or CDCl3 with or without 
internal standards at the Institute of Anorganic Chemistry 
and Structure Chemistry, Heinrich-Heine-Universität, 
Düsseldorf, Germany or the Department of Chemistry, City 
University of New York (CUNY), USA. Correlations (COSY; 
HH, HMBC, HQSC etc) and variants (DEPT-135) experiments 
were also done in these institutions. UV/visible spectra were 
obtained in a UV2102PC spectrophotometer with integrated 
data station (UNICO, USA) at the Faculty of Pharmaceutical 
Sciences, University of Nigeria, Nsukka. Other equipment 
used were soxhlet apparatus, rotary evaporator, separatory 
funnel, capillary tubes (0.5 mm id), electronic analytical 
balance (Metler Toledo, 0.001 max, England), Beam balance 
(Ohaus, England), venier calipers, glass columns for 
chromatography (4 cm 伊 150 cm; 2.7 cm 伊 70 cm), analytical 
and preparatory thin layer  chromatographic tanks, 20 cm
伊 20 cm, 20 cm 伊 10 cm or 20 cm 伊 5 cm chromatographic 
plates, amber coloured bottles, cannulated or normal 
syringes (1 mL, 2 mL, 5 mL, 10 mL and 20 mL).
2.4. Preliminary extractions from mistletoe parasitic on K. 
acuminata
2.4.1. Preparation of crude methanol extract
  Leaves of L. micranthus parasitic on K. acuminata were 
cleansed and dried under shade. They were then pulverized 
in mechanized laboratory grinder to produce fine powder. 
A total of 200 g of the powder was extracted in batches with 
500 mL methanol using a soxhlet extractor. The solvent was 
removed in vacuo, using rotary evaporator at (45 依 5) 曟
to dryness under dry air to give a dry extract which was 
weighed and its percentage yield was calculated. The dry 
extract was placed in a clean bottle container and stored in 
a refrigerator until use.
2.4.2. Experimental animals used
  Groups of albino mice (20-33 g) or rats (120-165 g) of both 
sexes were procured from the animal house, Department of 
Pharmacology and Toxicology, Faculty of Pharmaceutical 
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Sciences, and from the animal house, Department of 
Veterinary Parasitology and Entomology, Faculty of 
Veterinary Medicine, University of Nigeria, Nsukka. The 
blood specimens used in the study were collected from 
sheep in the Faculty of Veterinary Medicine, University 
of Nigeria, Nsukka. The animals were kept in standard 
laboratory conditions and fed with pelletized rodent 
commercial diet (Vital Feed Nig., Ltd) and water ad libitum 
throughout the study. They were exposed to 12 h light-
dark cycles. These investigations were conducted following 
laid down procedures by the relevant Ethical Committee on 
laboratory animal use and international rules were observed.
2.4.3. Preparation of antigen
  Fresh blood was obtained from a male sheep in the animal 
farm of the Faculty of Veterinary Medicine, University of 
Nigeria. The sheep red blood cells (SRBCs) were washed 
three times in a large volume of pyrogen-free sterile 
normal saline by centrifugation at 3 000 伊 g for 10 min 
on each occasion. The washed SRBCs were adjusted to a 
concentration of 109 cells/mL with normal saline and used 
for immunization and challenge[20].
2.4.4. Solvent fractionation of extract of mistletoe from K. 
acuminata
  Exactly 50 g of the dried aqueous methanol extract was re-
dissolved in minimal quantity of methanol and adsorbed 
on 250 g of silica gel (Silica gel 60G); that is in a ratio of 
1:5. This was dried and finely pulverized to provide a free 
flowing powder mass. This was poured into a stoppered 1 
L-size flat bottom flask. Then equal volumes (500 mL) of 
each solvent were used in repeated succession with strong 
but uniform agitation until the extract so obtained with the 
solvent became convincingly clear. Each time, the extract 
was filtered using filter papers. The next solvent higher in 
polarity was introduced for further extraction after drying 
off the preceding solvent. Five solvents in increasing order 
of polarity namely; n-hexane, chloroform, ethylacetate, 
acetone and methanol were used in the fractionation. 
Subsequently, the fractions obtained were evaporated to 
a small pourable mass under reduced pressure (rotary 
evaporator) maintained at a temperature of (40 依 5) 曟. The 
dried fractions obtained thereafter were weighed and the 
percentage yields calculated. The dry fractions were placed 
in clean plastic containers and stored in a refrigerator until 
use.
2.4.5. Phytochemical test on the crude extract and solvent 
fractions
  Phytochemical tests on the crude extract and all five 
solvent fractions were carried out. This was done as 
described by previous workers[21]. All reagents for the 
phytochemical tests were freshly prepared.
2.4.6. Immunomodulatory studies on solvent fractions
  The cell-mediated delayed type hypersensitivity reaction 
(DTHR) model was used to screen all the solvent fractions 
(n-hexane (HF), chloroform (CF), ethylacetate (EF), acetone 
(AF) and methanol (MF), at two dose levels of 250 and 500 
mg/kg body weight. Briefly, the method described by Chong 
and co-workers[22] in 1998 was used for the DTH studies. 
Briefly, 10 mL of blood was obtained from sheep and was 
washed three times with 20 mL of normal saline each for 10 
min in a centrifuge at 2 500 rpm. After washing and packing 
the cells at the same speed, a 2.5 % v/v SRBC suspension 
(1.0 伊 109 cells/mL) was then made in normal saline. Sixteen 
albino mice of either sex were selected at random and 
distributed into four groups (four mice per group). Starting 
with the methanol extract, the test animals in groups one to 
three received the extract at doses of 100, 200 and 400 mg/kg
intraperitoneally (i.p.) respectively for eight consecutive 
days while the fourth group served as the negative control. 
The diameters of the mice hind footpads were measured 
using a venier calliper. On the last day of treatment, the 
mice were all sensitized with a subcutaneous injection of 
0.1 mL of the freshly prepared SRBC suspension into the 
right hind footpad (RHFP). Five days post-sensitization, a 
challenging dose of 0.1 mL of the freshly prepared SRBC 
suspension was injected into the left hind footpad (LHFP). 
The induration was read 24 h later using a venier calliper. 
The above procedure was repeated using the fractions on 
separate groups of animals and fresh SRBC suspensions.
2.4.7. Isolation and purification of constituents from 
n-hexane fraction (HF)
  Exactly 10.5 g of the hexane fraction was chromatographed 
on silica gel (70-230 mesh, 1.2 kg) packed in a glass column 
(4 cm 伊 150 cm) with the bed of 105 cm in height. The 
elution was performed with gradient mixtures of hexane, 
hexane: ethyl acetate, ethyl acetate. Aliquots of 25 mL were 
collected and monitored as previously described. Fourteen 
(14) fractions F1-F14 (1-5, 6-25, 26-37, 38-41, 42-65, 66-
73, 74-93, 94-120, 121-136, 137-167, 168-175, 176-225, 
226-260, 261-269). These fractions were screened again by 
DTHR assay. F12 (176-225), 0.9 g the most active fraction 
in terms of immunostimulation, was chromatographed on 
silica gel (70-230 mesh, 650 g) packed in a glass column (2.5 
cm 伊 85 cm) with the bed of 65 cm in height  using gradient 
elution technique as above. This repeated chromatographic 
process afforded compounds I (34 mg), II (12 mg) and III (8 
mg) which were recrystallized in acetone-methanol mixture. 
Further purification of the compounds was achieved by a 
combination of analytical and prep-TLC. The phytochemical 
identities of the compounds were ascertained by standard 
procedures.
2.5. Cell proliferation studies with isolated compounds
2.5.1. Proliferation assay
  Single cell suspension of spleen cells of C57BL/6 mice 
was prepared by dispersion, straining and suspending in 
R10 culture medium (RPMI 1640, supplemented with 10 % 
FCS, 1 % Penicillin/Strep.) The splenocytes were thereafter 
incubated with CFSE cell tracer (3毺mol/L) at a density of 
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8 伊 107 cells/mL for 6 min at room temperature with gentle 
mixing. The labelling reaction was stopped by adding one 
volume of FCS after which the cells were washed twice with 
PBS. Thereafter, cells were plated into 96-well plates at a 
density of 1 伊 105 cells/well and incubated with different 
concentrations of compound I  (5, 25, and 100 毺g/mL), 
LPS (10 毺g/mL), and ConA (2 毺g/mL)  for 72 h. After 
washing the cells twice with PBS containing 0.5 % BSA and 
1 mmol/L sodium azide (PBS/BSA/Azid), cell proliferation 
was measured by flow cytometry and FACS analysis using 
FACScaliburTM. 
2.5.2. Quantification of CD69 expression
  Single cell suspension of spleen cells of C57BL/6 mice was 
prepared by dispersion straining and suspending in R10 
culture medium (RPMI 1640, supplemented with 10 % FCS, 
1 % Penicillin/Strep.) Thereafter, cells were plated into 96-
well plates at a density of 1 伊 105 cells/well and incubated with 
different concentrations of test extracts (5, 25, and 100 毺g/mL),
LPS (10 毺g/mL), and ConA (2 毺g/mL)  for 24 h. After 
washing the cells twice with PBS containing 0.5 % BSA and 
1 mmol/L sodium azide (PBS/BSA/Azid) and blocking FcR 
antibody; the expression of CD69 was determined by staining 
with FITCS-conjugated anti-CD69 antibody for 25 h at 4 曟. 
Expression of CD69 was measured by flow cytometry and 
FACS analysis on FACS FACScaliburTM and expressed as 
mean fluorescence intensity.
2.5.3. Real time polymerase chain reaction (RT-PCR) test
  The effect of 1 毺g/mL, 5 毺g/mL, and 10 毺g/mL of 
compound I on interleukin-8 expression was assessed by 
real time polymerase chain reaction assay and compared 
with Juzen-taito-to (JTT; an oriental herbal formulation for 
immunostimulation) as positive standard. Briefly, human 
monocytic leukemia cells (THP-1) were plated onto each 
well of a 6-well plate at about 20 % confluence in 2 mL 
RMPI medium with 10 % foetal bovine serum (FBS) and 
incubated for 24 h to allow them to recover from passage. 
Cells were treated with compound I (1 mg/mL in DMSO; 
final concentrations 1, 5, 10 毺g/mL) for 4 h. DMSO vehicle 
control was used as the negative control in this assay, 
whereas Juzen-taito-to was used as positive control. 
RNeasy mini kit (Qiagen) was used to purify the total RNA. 
RNA samples were quantified using UV absorbance at 260 
nm. Samples with the 260 nm/280 nm ratio ~ 1.8 or higher 
were used for the subsequent study. The first strand cDNA 
samples were synthesized with Gibco BRL Superscript 
Choice System and oligo (dT) 12-18 primer. TaqMan® Gene 
Expression Assays (Applied biosystems) were carried out 
on Applied Biosystems 7500 Real-Time PCR system using 
pre-optimised assays for interleukin-8 (IL-8) and GAPDH 
(endogenous control). The 驻驻 CT method was employed to 
quantify differential gene regulation. The raw data were first 
normalised by the endogenous control (GAPDH). The relative 
quantification (RQ) values, i.e. the fold-change ratios, were 
obtained by comparing the normalized data against the 
DMSO control. Minimum triplicate experiments were carried 
out.
2.6. Statistical analyses
  The results obtained (analysed by SPSS version 11), were 
recorded as the mean values with the standard error in 
mean (SEM) and statistical significance between treated 
and control groups were evaluated by the Students’ t-test 
and one way analysis of variance (ANOVA; Fischer LSD post 
hoc test). Differences between means of treated and control 
group and also between solvents and extracts at P<0.05 or 
P<0.01 was considered significant.
3. Results
  The phytochemical chemical profile of crude aqueous 
methanol extract of mistletoe is shown in Table 1. From the 
table, the Eastern Nigeria mistletoe is phytochemically, a 
richly constituted parasitic plant. In terms of quantities in 
gram weights of the recovered solvent fractions, the least 
polar of the solvents under consideration, n-hexane afforded 
the highest yield of 14.0 g or 28.0% yield while acetone gave 
the least yield of 2.2 g (4.4%). The n-hexane and chloroform 
fraction were both dark greenish and highly resinous while 
the ethylacetate fraction was moderate in resin content.
  The result of the comparative phytochemical tests on all 
the different solvent fractions as well as the crude aqueous 
methanol extract is shown in Table 2. It is evident that 
the non-polar solvents extracted mainly the non-polar 
constituents while the moderately polar solvents, especially 
ethylacetate extracted the moderately polar constituents 
such as flavonoids and other polyphenolics. Acetone 
and methanol obviously showed presence of highly polar 
constituents.
  The result of the DTHR of the different solvent fractions 
is as shown in Figure 1. In summary, at 500 and 250 mg/kg 
Table 1
The result of the preliminary phytochemical analysis.
Constituent Presence or absence
Carbohydrate +++
Alkaloids +++
Reducing sugar ++
Glycoside +++
Saponin ++
Tannin ++
Flavonoids ++
Steroids ++
Resins +++
Terpenoids ++
Carotenoids ++++
Fats and oil -
Proteins +
Acidic compound +
+++ = present in very high concentration; ++ = present in moderately 
high concentration; + = present in small concentration; - = not 
present.
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body weight dose levels, the percentage stimulation observed 
were as follows: chloroform fraction-311.11  and 122.22%, 
ethyl acetate fraction-193.38 and 95.56%, n-hexane-
155.56 and 3.50%, acetone fraction-77.78 and 51.11% 
and methanol fraction-68.89 and 24.44% respectively. 
Levamisole, a known potent immunostimulant, afforded a 
stimulation of 68.89% at a dose of 2.5 mg/kg i.p. The order 
of potency is therefore, chloroform fraction>ethylacetate 
fraction>n-hexane fraction>acetone fraction>methanol 
fraction. All responses were dose-dependent. These values 
exhibit statistically (P<0.05) significant difference with that 
of the standard immunostimulant, Levamisole. Repeated 
fractionation and purification of the n-hexane fraction 
led to the isolation of a major triterpenoid ester alongside 
(compound I) two other minor closely related triterpenoidal 
esters (compounds II and III) all, of the lupane series, 
specifically lupeol. The general structure of the triterpenoids 
is shown in Figure 2. Compound I was obtained as a white 
amorphous compound; yield (34 mg), m.p = 107.0 曟.  A 
solution of Compound I in chloroform showed positive 
reaction to concentrated sulphuric acid (Salkowski test) 
indicating a terpenoid. UV 毸max (CHCl3) nm (毰): 250 (11 
100), 268 (1 890.4), 289 (1 160), IR (KBr) cm-1: 3167 (OH), 2 872 
(CH str), 1 728 (C=O), 1 645 (C=C), 1 384 (isopropylene side 
chain), HREIMS [M]+ m/z: 696.602 2 (calculated for C46H80O4) 
with 7 double bond equivalent (DBE). [M+H]+ [-H2O] m/z: 
679.602 1 (loss of water), [M+Na]+ m/z: 719.593 6, [M+HCOO]- 
m/z: 741.604 5, [M+Cl]- m/z: 731.575 1, [M+CF3COO]
- m/z: 
809.592 0, (all calculated for C46H80O4).  EIMS (relative int.), 
M+ (m/z): 696.
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Figure 1. DTHR assay of fractions from the crude extract.
 
Figure 2. Structures of the triterpenoids.
  1H-NMR (CDCl3, 600 or 500 MHz): δ 4.66(1H,d, H-29), δ 
4.57 (1H, br,s, H-29), δ 4.45 (1H,dd, H-3), δ 4.14 (1H, dd, 
H-5), δ 3.79 (1H,dd, H-15) seven singlet methyls at δ(0.84, 
1.67, 0.81, 0.83, 0.82, 1.06, 0.97, methyls of lupeol moiety) 
and a triplet-doublet methyl signal at δ 0.86 (terminal 
methyl of fatty acid chain), multiple flexible and overlapping 
methylenes of the fatty acid chain at δ~1.22-1.27.
   13C-NMR (CDCl3, 500 MHz)  at δ 38.62 (C1), 23.96 (C2), 80.37 
(C3), 37.77 (C4), 52.31 (C5), 28.25 (C6), 72.71 (C7), 48.05 (C8), 
50.39 (C9), 37.42 (C10), 20.81(C11), 25.02 (C12), 37.63 (C13), 
49.15 (C14), 68.25 (C15), 45.90 (C16), 42.78 (C17), 48.29 (C18), 
47.77 (C19), 10.52 (C20), 30.33 (C21), 39.99 (C22), 16.65 (C23), 
28.10 (C24), 15.82 (C25), 11.16 (C26), 8.60 (C27), 42.78 (C28), 
109.96 (C29), 19.60 (C30); fatty acid chain: δ 173.91 (C1′-
ester carbonyl), 35.05 (C2′), 25.38 (C3′), 29.82 (C4′), 29.69 (C5′), 
29.59 (C6′), 29.49 (C7′), 29.39 (C8′), 29.92 (C9′), 29.90 (C10′), 29.89 
(C11′), 29.87 (C12′), ? (C13′), 32.15 (C14′), 22.92 (C15′), 14.36 
(C16′). 
  DEPT-135 signals observed for 8 methyls, 23 methylenes, 8 
methines carbons. 7 quaternary carbons were not shown in 
the DEPT. 1H-COSY, HSQC, and HMBC studies confirmed all 
the fragments and connectivities. Positive NOE and NOESY 
confirmed spatial arrangements or configurations. Spectral 
data correlates well with literature data for dihydroxylated 
hydroxylated esterified lupane nucleus (lupeol) and was 
elucidated to be 7毬, 15毩-dihydroxy-lup-20(29)-en-3毬
-O-palmitate.
  Compound II was isolated as a white amorphous compound; 
yield (12 mg), m.p = 107.0 曟. UV 毸max (CHCl3) nm (毩): 250 
(11 100), 268 (1 890.4), 295 (1 160). IR (KBr) cm-1: 3 167 (OH), 
2 872 (CH str), 1 728 (C=O), 1 645 (C=C), 1 384 (isopropylene 
side chain). HREIMS [M]+ m/z: 724. 637 4 (calculated for 
C48H84O4) with 7 double bond equivalent (DBE).  [M+H]
+ 
[-H2O] m/z: 707.632 9 (loss of water), [M
+NH4]+ m/z: 742.670 5, 
[M+HCOO]- m/z: 769.635 4, [M+Cl]- m/z: 731.575 1, [M+CF3COO]
- 
m/z: 837.621 3, (all calculated for C48H84O4).  EIMS (relative 
int.), M+ (m/z): 724.
  Compound III was observed as a white amorphous 
compound; yield (8 mg), m.p = 107.0 曟. UV 毸max (CHCl3) 
nm (毰): 250 (11 100), 268 (1 890.4), 295 (1 160). IR (KBr) 
cm-1: 3 167 (OH), 2 872 (CH str), 1 728 (C=O), 1 645 (C=C), 1 
384 (isopropylene side chain). HREIMS [M]+ m/z: 752.667 
1 (calculated for C50H88O4). [M
+H]+ [-H2O] m/z: 735.663 6 (loss 
of water), [M+HCOO]- m/z: 797.664 8, [M+Cl]- m/z: 787.635 
1, [M+CF3COO]
- m/z: 865.652 1, (all calculated for C50H88O4). 
EIMS (relative int.), M+ (m/z): 752.
  The 1H-NMR and 13C-NMR data of compounds II and III 
were found to be similar to those of Compound I except that 
two and four extra methylene groups were observed for them 
respectively. These extra methylene groups were revealed 
by 2-D correlation studies to be part of the fatty acid chain. 
Spectral data for compound II correlate well with literature 
data for hydroxylated esterified lupane nucleus and was 
elucidated to be 7毬, 15毩-dihydroxy-lup-20(29)-en-3
毬-O-stearate while the spectral data of Compound III 
correlate well with literature data for hydroxylated esterified 
lupane nucleus and was elucidated to 7毬, 15毩-dihydroxy-
lup-20(29)-en-3毬-O-decadecanoate. All the original 
spectra data are with the author for correspondence.
  Table 3 and 4 show some potentiating abilities of compound 
Omeje Edwin Ogechukwu et al./Asian Pacific Journal of Tropical Medicine (2011)514-522 519
1, in its present chemical structure, on mice splenocytes 
(C57B1/6) and the early activation marker (CD69) respectively. 
There was also observed, a poor action of the compound on 
IL-8 receptor expression using the real-time polymerase 
chain reaction assay. Compound I did not strongly potentiate 
these cells or mediator types at the tested doses. There were 
very significant difference in activities between the test 
compounds and the controls (P<0.05; P<0.001).
4. Discussion
  The phytochemical profiles of extracts and solvent fractions 
of the Eastern Nigeria mistletoes as well as its acute toxicity 
have been reported severally[23]. The established data 
confirmed that the extracts and fractions of this species 
of mistletoes are optimally rich in phytoconstituents and 
exhibit high margin of safety in rodents (mice and rats). 
However, the quantities and qualities of these constituents 
are both dependent on season of harvest and also on the 
particular host tree from the mistletoes are harvested[24]. 
These findings, which make the Eastern Nigeria mistletoes 
better than its European counterpart, Viscum album in 
terms of safety, provide additional credence to its known 
multiple folkloric and ethno-medicinal uses. The extracts 
from the different host trees exhibited very high margin of 
safety (between 5 500 to 11 000 mg/kg). The apparently high 
LD50 implies that the extracts are very safe in mice when 
administered intraperitoneally[23]. These findings are in 
agreement with previous reports on the acute toxicities of 
these species of Eastern Nigeria mistletoe[16]. Furthermore, 
recent data suggest that both the crude extracts from leaves 
and berries of Eastern Nigeria mistletoes are moderately 
safe, exhibiting no sub-acute toxicity[25,26]. They reported 
that histopathogical examination of major organs after the 
toxicity studies revealed no damage to them by the extracts. 
Furthermore, it has been reported that mistletoe extracts 
do not produce adverse biochemical changes following a 
Table 2
Phytochemical analyses on crude and solvent fractions.
Constituent Solvent fractions
Crude  n-Hexane Chloroform Ethylacetate Acetone Methanol
Carbohydrate ++++ - - ++ ++ +++
Alkaloids ++++ - + + + +++
Reducing sugar +++ - - + + +
Glycoside ++++ - + +++ +++ +++
Saponin ++ - - - + ++++
Tannin +++ - - +++ +++ ++++
Flavonoids ++ - + ++++ +++ ++
Steroids +++ +  ++++ +++ + +
Resins ++++ ++++ + ++ - -
Terpenoids +++ + ++++ +++ + +
Proteins +++ - - +++ ++ ++
Fats and oil - - - - - -
Acidic compound + - - - + +
Key: ++++ = present in very high concentration; +++ = present in high concentration; ++ = present in moderate concentration; += present in 
small concentration; - = not present. 
Table 3
Proliferation potentials of Compound 栺 on C57B1/6 Spleenocytes.
Drug Dose (毺g/mL) Percentage proliferation (%)
Compound 栺    5 18.34 依 1.56
Compound 栺                                      25 20.08 依 0.83
Compound 栺 100 24.44 依 2.58
LPS   10 34.61 依 0.44
Con A    2 34.01 依 0.32
Control Vehicle   7.69 依 0.41
Table 4
Proliferation potentials of Compound 栺 on CD69 cells.
Drug Dose (毺g/mL) Stimulation  Percentage yield stimulation (%)
Compound 栺     5  2.45 依 0.07   33.14
Compound 栺   25  2.71 依 0.06   60.36
Compound 栺 100  3.16 依 0.06   86.98
LPS   10  5.42 依 0.11 220.71
Con A     2  5.27 依 0.08  211.83
Control Vehicle  1.69 依 0.05 -
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maximal dose of 827 mg/kg body weight[27]. It is therefore 
reasonable to postulate at this time, that the Eastern Nigeria 
mistletoe might be safer than other continental mistletoes 
including the European version, V. album which has an 
established LD50 value of less than 1 000 mg/kg. 
  However, the chronic toxicity study should be carried 
out in order to validate its safety on long term use. Recent 
researches with crude extracts of mistletoes harvested from 
different host trees established their immunomodulatory 
properties in both cell- and humour-mediated immune 
responses[19,23,28-30]. Interestingly, we have been able to 
establish that heat (soxhlet extraction) does not destroy the 
immunomodulatory activities of the extracts obtained from 
mistletoe harvested from K. acuminata[31]. This suggests in 
strong terms that immunostimulating activity of the mistletoe 
extracts does not mainly depend on any possible heat 
labile constituents. These findings support the documented 
report on European and Korean mistletoes, which 
emphasized that their main immunomodulatory principles 
were glycoproteins and thionin toxins called lectins and 
viscotoxins respectively[32]. An elegant research also 
established the imunogenicity of mistletoe lectins following 
intranasal co-administration with herpes simplex virus 
glycoproteins D2[33]. The presence of these highly mitogenic 
(immunogenic) compounds in V. album may account for its 
low therapeutic index. Another group of authors assessed 
crude methanol extracts of mistletoe harvested from cashew 
and cocoa trees for antioxidant activities and found them 
active[34]. 
  Antioxidant potentials of mistletoe extracts and fractions 
harvested from different host trees have been confirmed 
(Omeje and Osadebe, unpublished data). Mistletoe 
harvested from K. acuminata was therefore the overall most 
potent in terms of immunostimulation and antioxidation 
with enhanced macrophage activation and cell proliferative 
abilities. Further bioassay-guided solvent fractionation 
of the crude extract (using DTHR as model guide) showed 
potency in the order of chloroform fraction >> ethylacetate 
fraction > n-hexane fraction> methanol fraction > acetone 
fraction. At the dose levels of 500 and 250 mg/kg body 
weight, the percentage stimulation observed were as follows; 
chloroform fraction-311.11  and 122.22%, ethyl acetate 
fraction-193.38 and 95.56%, n-hexane-155.56 and 3.50%, 
acetone fraction-77.78 and 51.11% and methanol fraction-
68.89  and 24.44% respectively. Levamisole, a known potent 
immunostimulant, afforded a stimulation of 68.89% at a dose 
of 2.5 mg/kg. The DTHR is mediated by interferon-gamma 
(IFN-毭) producing CD4+ (TH1) or CD8+ (TC1) T cells[35]. It 
usually takes 24–72 h to develop and involves activation 
of T cells, which results in the mobilization of monocytes 
and lymphocytes to areas requiring immune stimulation. 
DTHR is known to be initiated by reaction between antigen-
specific T cells and the antigen, which results in the release 
of lymphokines that affect a variety of cell types, especially 
macrophages. Thus, DTHR is an enhancement of “lympho-
proliferative” response. SRBC is a T-dependent antigen 
hence, the first dose sensitized the T-lymphocytes to 
become activated to synthesize and release physiologically 
active substances such as macrophages, monocytes, 
polymorphonuclear leukocytes and probably, other non-
sensitized leucocytes into the area of antigen contact. The 
observed stimulation supports the use of mistletoe extracts 
as immune boosters. 
  The reduction in DTHR response at higher doses may 
be an indication that Eastern Nigeria mistletoe may as 
well possess anti inflammatory activity at such doses. The 
phytochemical composition of the three most active solvent 
fractions, revealed that steroids, terpenoids, alkaloids, 
flavonoids were the likely immunomodulatory constituents. 
There are documented evidences supporting the use of these 
constituents as immunomodulatory agents[36-40]. Bioassay-
guided fractionation of the n-hexane fraction led to the 
isolation of a major triterpenoidal ester (compound I) and 
two minor ones (compounds II and III) of the same class. 
Compound I particularly could not enhance interleukin-8 
(IL-8) expression using a real time PCR assay. IL-8, a 
T-helper cell type 2 (Th2) macrophage derived cytokine 
mediates the attraction of neutrophil (PMN) to target sites 
and thereby mediates anti-inflammation[11]. It is known 
that T-cells secrete a number of cytokines which mediate 
cellular immune functions at either ends[41]. This implies 
that compound I lacked pronounced immunostimulatory 
function on cytokine (IL-8) activation and other possible 
macrophage functions. It is therefore a possible anti-
inflammatory agent. A recent elegant review provided a 
strong evidence for the relationship between inflammation 
and tumourigenesis pathways mediated by cytokines, 
chemokines and other immunogenic agents[42].  Similarly, 
compound I could not strongly potentiate the proliferation 
of mice splenocytes (C57B1/6) cells on the early activation 
marker, CD69 cells using flow cytometry techniques at 
the tested doses.  These findings provide strong evidence 
that this major triterpenoidal ester may be a good anti-
inflammatory candidate. These compounds alongside other 
numerous constituents of the Eastern Nigeria mistletoe 
therefore, may become good leads for the development of 
potent anti-inflammatory as well as anti-cancer agents 
in the near future. However, immunological reactions are 
intricately complex processes and it is obvious that this 
assumption will require further validation using multiple 
experimental models. 
  Compound I was recrystallized in acetone-methanol to 
yield white amorphous compound; yield (34 mg) and melting 
point 107.0 曟. The spectroscopic were obviously typical of a 
triterpenoidal ester. Its 1H-NMR spectrum exhibited signals 
due to seven singlet methyls and a triplet-doublet methyl 
at δ 0.86. The presence of a hydroxyl bearing methine 
at 4.14 ppm and a triplet-doublet methine at δ 2.32 are 
reminiscent of a lupeol-type triterpene[43,44]. Additionally, 
a terminal methyl around δ 0.86 and a strong methylene 
proton signals around δ 1.26 were indicative of a fatty acid 
which was supported by the appearance of the carbonyl 
ester in the 13C-NMR spectrum. Furthermore, the signal at 
δ 4.45 (1H, dd, J=4.9, 12.6Hz) was ascribable to H-3 in 
the triterpene moiety by the 1H-1H COSY, HSQC and HMBC. 
13CNMR (CDCl3, 500 MHz): δ 173.91(ester carbonyl), δ 150.52 
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(double bonded carbon), δ 109.96 (double bonded carbon), 
δ 80.37 (oxygenated carbon), δ 72.71 (oxygenated carbon), 
δ 68.25 (oxygenated carbon), δ 52.31 (methine carbon), 
δ 50.39 (methine carbon), δ  49.15 (quaternary carbon), 
δ 48.29 (methine carbon), δ 48.05 (quaternary carbon), 
δ 47.77 (methine carbon), δ 45.89 (methylene carbon), δ 
42.78 (quaternary carbon), δ 39.99 (methylene carbon), δ 
38.62 (methylene carbon),  δ 37.77 (quaternary carbon), δ 
37.63 (methine proton), δ 37.42 (quaternary proton) δ 35.05 
( methylene carbon), δ 14.36 (terminal methyl of fatty acid 
chain). 
  Although the 13C-NMR showed 44 carbons, the remaining 
carbons were revealed to have been in a highly flexible 
and overlapping methylene chain, a feature confirming 
the presence of traces of multiple fatty acid chain.  The 
unequivocal structural build up was achieved with 
fragments formed from HSQC experiments. In summary, 
DEPT-135 signals of compound I were observed for 8 
methyls, 23 methylenes, 8 methines carbons with 7 
unobserved quaternary carbons. 1H-COSY, HSQC, and HMBC 
studies confirmed all the fragments and connectivities. 
Positive NOE and NOESY confirmed spatial arrangements or 
configurations. Spectral data correlates well with literature 
data for hydroxylated esterified lupane nucleus (lupeol)[43-48] 
and was elucidated to be 7毬,15毩-dihydroxy-lup-20(29)-
en-3毬-O-palmitate.
  Compounds II and III were similarly elucidated as 7毬,15
毩-dihydroxy-lup-20(29)-en-3毬-O-stearate and 7毬,15
毩-dihydroxy-lup-20(29)-decadecanoate respectively as 
was previously shown with compound I. The only difference 
in there spectral data was from the HREIMS which showed 
additional masses assignable to extra methylene groups 
in the fatty acid chain. The 13C-NMR could not show these 
differences simply because of overwhelming overlap from 
the methylene groups.  Although related compounds have 
been reported to occur in plant of other classes[48,49], it 
appears that this is the first report of their occurrence in 
mistletoe of Eastern Nigeria origin. Strikingly, the presence 
of two hydroxyl groups in the compound makes it a novel 
and unique lupeol based long-chain fatty acid ester 
isolated for the first time from the Eastern Nigeria mistletoe. 
However, compound I only has been reported present in 
Japanese mistletoe[45].
  There is overwhelming evidence from the foregoing research 
that these triterpenoidal esters of the Eastern Nigeria 
mistletoes are good candidates of immunomodulation. 
However, it appears that fractionation and purification of 
the n-hexane extract produced single pure compounds 
that failed to strongly enhance certain cell types involved 
in the mediation of immunologic reactions and therefore 
will be good candidates of anti-inflammation and possible 
development as anti-neoplastic agents.
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